These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36066160)

  • 1. Regional and annual patterns in respiratory virus co-infection etiologies and antibiotic prescriptions for pediatric mycoplasma pneumoniae pneumonia.
    Sung M; Choi HJ; Lee MH; Lee JY; Kim HB; Ahn YM; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Park KS; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; Yu ST; Roh EJ; Lee ES; Kim JT; Kim BS; Hwang YH; Sol IS; Yang HJ; Han MY; Yew HY; Cho HM; Kim HY; Hn YH; Im DH; Hwang K; Yoo J; Jung SO; Jeon YH; Shim JY; Chung EH
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5844-5856. PubMed ID: 36066160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia.
    Zhou Y; Wang J; Chen W; Shen N; Tao Y; Zhao R; Luo L; Li B; Cao Q
    BMC Infect Dis; 2020 Aug; 20(1):633. PubMed ID: 32847534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
    Choi JH; Seong GM; Ko Y; Kim YR; Kim C
    Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
    [No Abstract]   [Full Text] [Related]  

  • 4. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
    Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
    BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of variables associated with prolonged admission duration in children with Mycoplasma pneumoniae pneumonia.
    Sung M; Roh EJ; Lee ES; Lee JY; Kim HB; Ahn Y; Eun BW; Kim JK; Kim HY; Jung SS; Kim M; Kang EK; Yang EA; Lee SJ; Park Y; Seo JH; Lee E; Yang ES; Cho HM; Shin M; Chung HL; Jang YY; Choi BS; Kim H; Jung JA; You ST; Lee MH; Kim JT; Kim BS; Hwang YH; Shim JY; Yang HJ; Han MY; Yew HY; Kim DH; Jeong SO; Whang K; Lee E; Jeon YH; Chung EH
    Clin Respir J; 2022 Nov; 16(11):756-767. PubMed ID: 36205104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
    Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
    J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide-Resistant Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia.
    Chen YC; Hsu WY; Chang TH
    Emerg Infect Dis; 2020 Jul; 26(7):1382-1391. PubMed ID: 32568052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of macrolide resistance in pediatric
    Jiang TT; Sun L; Wang TY; Qi H; Tang H; Wang YC; Han Q; Shi XQ; Bi J; Jiao WW; Shen AD
    Front Cell Infect Microbiol; 2023; 13():1181402. PubMed ID: 37249975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Detection and Characterization of Macrolide-Resistant
    Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
    Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent acute reduction in macrolide-resistant Mycoplasma pneumoniae infections among Japanese children.
    Nakamura Y; Oishi T; Kaneko K; Kenri T; Tanaka T; Wakabayashi S; Kono M; Ono S; Kato A; Kondo E; Tanaka Y; Teranishi H; Akaike H; Miyata I; Ogita S; Ohno N; Nakano T; Ouchi K
    J Infect Chemother; 2021 Feb; 27(2):271-276. PubMed ID: 33500118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Co-detected Respiratory Viruses and Patient Age to the Clinical Manifestations of Mycoplasma Pneumoniae Pneumonia in Children.
    Han MS; Yun KW; Lee HJ; Park JY; Rhie K; Lee JK; Lee H; Kwak YH; Kim DK; Suh DI; Choi EH
    Pediatr Infect Dis J; 2018 Jun; 37(6):531-536. PubMed ID: 29095244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.
    Okada T; Morozumi M; Tajima T; Hasegawa M; Sakata H; Ohnari S; Chiba N; Iwata S; Ubukata K
    Clin Infect Dis; 2012 Dec; 55(12):1642-9. PubMed ID: 22972867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
    Qu J; Chen S; Bao F; Gu L; Cao B
    Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide-Resistant Mycoplasma pneumoniae Infections in Children, Ohio, USA.
    Lanata MM; Wang H; Everhart K; Moore-Clingenpeel M; Ramilo O; Leber A
    Emerg Infect Dis; 2021 Jun; 27(6):1588-1597. PubMed ID: 34013867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observational retrospective clinical study on clinical features of macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese pediatric cases.
    Li P; Wang W; Zhang X; Pan J; Gong L
    Sci Rep; 2024 Mar; 14(1):5632. PubMed ID: 38453960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis.
    Kim K; Jung S; Kim M; Park S; Yang HJ; Lee E
    JAMA Netw Open; 2022 Jul; 5(7):e2220949. PubMed ID: 35816304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
    Morozumi M; Takahashi T; Ubukata K
    J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.